To perform the translation, cultural adaptation, and validation of the NOSE-Perf Scale to Brazilian Portuguese. This study was divided into two stages. In the first stage, the questionnaire was submitted for translation and cultural adaptation, following the guidelines recommended by the ISPOR Task Force (International Society for Pharmacoeconomics and Outcomes Research). Then, the Brazilian Portuguese version of the NOSE-Perf scale was applied to a group with septal perforation and a control group. The group with perforation answered the questionnaire again after one month. Internal consistency, test-retest reliability, and discriminant validity were assessed. The Brazilian Portuguese version of the NOSE-Perf scale was applied to 32 participants, 16 from the group with septal perforations and 16 controls. The instrument obtained high internal consistency, with Cronbach's alpha scores of 0.986. High reliability was also obtained, with Spearman's correlation coefficient of 0.996 (p < 0.001) and the intraclass correlation coefficient of 0.965 with a 95% Confidence Interval (95% CI) of 0.886‒0.988. The NSP group obtained a mean total score of 13.8 ± 12.6 and the control group a score of 2.3 ± 1.8, with a statistical difference between the groups (p < 0.001), demonstrating good discriminant validity. The Brazilian Portuguese version of the NOSE-Perf scale is a reliable and valid instrument for measuring symptoms in patients with nasal septum perforations. Level 2-Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence.
23 September 2023 in Brazilian Journal of Otorhinolaryngology
According to an extensive database, the Objective is to compare surgical versus non-surgical treatment through Propensity Score (PS) for patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC). We retrospectively evaluated epidemiological data from 8075 patients with OPSCC diagnosed between 2004 and 2014 and used PS matching to analyze possible prognostic factors for its outcomes with regression analyses. Cox multiple regression analysis to study survival after PS matching shows that type of treatment was associated with death with a hazard ratio of 1.753 (p0.05). In the surgical treatment group, overall survival was 79.9% at one year, 36.4% at five years, and 20.5% at ten years. Disease-free survival was 90.1%, 64.8%, and 56.0% at 1, 5, and 10-years, respectively. In the non-surgical treatment group, overall survival was 60.6% at one year, 21.8% at five years, and 12.7% at ten years. Disease-free survival was 90.8%, 67.2%, and 57.8% at 1, 5, and 10-years, respectively. Patients in the surgical treatment group had better outcomes related to survival. Recurrence is associated with the survival of OPSCC cancer. Recurrence-free survival is similar to both treatments. 2C.
5 May 2025 in Journal of Neurological Surgery Part B: Skull Base
This study aimed to better learn how pituitary surgery centers around the world perform the reconstruction step of endoscopic endonasal transsphenoidal pituitary surgery and to understand the rationale behind their strategies. Survey. Representatives of 311 centers across 54 countries were invited. Online 15-question questionnaire. Representatives of 121 centers from 36 countries responded to the survey. We recorded a preference for multilayer reconstruction in all scenarios presented. In cases of intraoperative cerebrospinal fluid (CSF) leak and extended approaches, respondents reported greater use of autologous materials, such as fat grafts, fascia lata, and pedicled flaps. Although there was no statistical significance for most of the scenarios analyzed, we observed a greater tendency to use pedicled flaps in centers with ENT specialists on the team and a lower likelihood of using them in centers with a higher surgical volume. For cases where no CSF leak is expected preoperatively, the overall preference was for the use of rescue flaps (56.10%), especially in centers in which an ENT surgeon was present (69.77%). Once a nasoseptal flap has been created, the preference is for the nasal septum to heal by secondary intention (52.23%). This survey provides additional evidence of the wide variability in practice and strategies among specialized pituitary/skull base surgery centers worldwide. Trends toward multilayer reconstruction, use of the nasoseptal flaps, and autologous grafts were observed. The presence of an otolaryngologist on the team influences the reconstruction strategy adopted at the institution.
18 April 2025 in European Archives of Oto-Rhino-Laryngology
To descriptively analyze the epidemiological data, clinical stage, and outcomes of oropharyngeal squamous cell carcinoma in the state of São Paulo, Brazil, and to estimate the influence of clinical stage and treatment type on overall and disease-free survival. We retrospectively analyzed epidemiological data from the São Paulo Cancer Center Foundation database relative to patients with oropharyngeal squamous cell carcinoma diagnosed between 2004 and 2014 in the state of São Paulo. Univariate and multivariate Cox regression analyses were performed to assess factors associated with the outcomes. A forward stepwise selection procedure was used. Survival curves were estimated by the Kaplan-Meier method and compared by the Gehan-Breslow-Wilcoxon test. A total of 8075 individuals with oropharyngeal squamous cell carcinoma were identified. Of these, 86.3% were diagnosed at an advanced stage and 13.7% at an early stage. Only 27.2% of patients were treated surgically, whereas 57.5% were treated medically. Patients undergoing surgery had longer overall survival than those receiving medical treatment in both early- and advanced-stage oropharyngeal squamous cell carcinoma. However, there was no significant difference in disease-free survival between surgical and medical treatment. No significant difference in disease-free survival between medical and surgical treatment suggests similar complete remission rates with both approaches. Patients receiving medical treatment had shorter overall survival, which may be due to complications from chemotherapy and radiotherapy. However, we cannot confirm this relationship based on the data provided by the São Paulo Cancer Center Foundation. Prospective studies are warranted to assess whether the lower overall survival rate in patients receiving medical treatment is secondary to complications from chemotherapy and radiotherapy. 2C.
16 February 2026 in European Archives of Oto-Rhino-Laryngology
Purpose: Extranasopharyngeal angiofibromas of the sinonasal tract (ENA-SNT) are exceptionally rare tumors that remain poorly characterized in the literature. We aim to systematically review and synthesize the clinical characteristics, management, and outcomes of ENA-SNT. Methods: This review adhered to PRISMA guidelines. A literature search was conducted across major databases, including PubMed, EMBASE, Web of Science, and Google Scholar. Articles that reported ENA-SNT cases in humans were eligible for inclusion. Data extraction and quality assessment were independently performed by two reviewers. Results: A total of 145 studies were included, comprising 163 patients. The mean age was 28.8 years (range, 0–78), with a male-to-female ratio of 2.1:1. The nasal septum (33.3%), inferior turbinate (16.6%), and maxillary sinus (16.0%) were the most frequent tumor sites. Common symptoms included nasal obstruction (73.0%) and epistaxis (68.1%), often in combination (55.2%). Angiography demonstrated no hypervascularity in 23.1% of cases; when present, the internal maxillary artery supplied the tumor in 96.1%. Preoperative biopsy caused brisk bleeding in 44.5%. Surgery was the primary treatment in 94.4% of cases, with a recurrence rate of 5.3% and an average time to recurrence of 3.8 months. Intracranial and orbital involvement were rare: 1.84% and 2.45%, respectively. Conclusion: This review supports ENA-SNT as a clinical entity distinct from juvenile nasopharyngeal angiofibroma. Symptoms develop more rapidly, but the tumor is less aggressive, less vascularized, and has a better prognosis. ENA-SNT can occur across all age groups and in female individuals. Surgical resection is the treatment of choice, with low recurrence rates.